Convatec Continence Care’s Post

As a key player in the second stage of a two-stage revision for total joint arthroplasty, choosing the right bone cement is crucial. Since its introduction to the U.S. market in 2021, 𝐏𝐀𝐋𝐀𝐂𝐎𝐒® 𝐑+𝐆* 𝐚𝐧𝐝 𝐌𝐕+𝐆* 𝐩𝐫𝐨 – 𝐀𝐥𝐥-𝐢𝐧-𝐎𝐧𝐞 𝐅𝐢𝐱𝐚𝐭𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦™ has brought innovation into infection management. 🤔 Why an all-in-one mixing and application system pre-filled with antibiotic loaded bone cement, suitable for use with or without vacuum? ✅  It contains the aminoglycoside antibiotic 𝐠𝐞𝐧𝐭𝐚𝐦𝐢𝐜𝐢𝐧 to protect the cured bone cement and contiguous tissue against colonization by bacteria that are sensitive to gentamicin.¹ As a broad-spectrum antibiotic, gentamicin is also effective against 70% of the bacteria that cause PJI.² ✅  Enhanced safety features ✅  Integrated education ✅  Compared to systemic antibiotic prophylaxis alone, the combination of local and systemic administration of antibiotics achieves the best preventive results in arthroplasty.³⁻⁵ ✅  A vacuum cartridge mixing system optimizes the surface porosity, increasing cement resistance to crack growth.⁶⁻⁷   Have you used PALACOS® pro R+G* or MV+G* in your two-stage revision procedure yet? What do you believe are the benefits of an all-in-one fixation system?   Let us know your thoughts in the comments below! 💬 👇 Click here to learn more: https://lnkd.in/gEQe_hC2   *𝑃𝐴𝐿𝐴𝐶𝑂𝑆® 𝑅+𝐺 𝑝𝑟𝑜 𝑎𝑛𝑑 𝑀𝑉+𝐺 𝑝𝑟𝑜 𝑖𝑠 𝑖𝑛𝑑𝑖𝑐𝑎𝑡𝑒𝑑 𝑓𝑜𝑟 𝑢𝑠𝑒 𝑖𝑛 𝑡ℎ𝑒 𝑠𝑒𝑐𝑜𝑛𝑑 𝑠𝑡𝑎𝑔𝑒 𝑜𝑓 𝑎 𝑡𝑤𝑜-𝑠𝑡𝑎𝑔𝑒 𝑟𝑒𝑣𝑖𝑠𝑖𝑜𝑛 𝑓𝑜𝑟 𝑡𝑜𝑡𝑎𝑙 𝑗𝑜𝑖𝑛𝑡 𝑎𝑟𝑡ℎ𝑟𝑜𝑝𝑙𝑎𝑠𝑡𝑦 𝑎𝑓𝑡𝑒𝑟 𝑡ℎ𝑒 𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑖𝑛𝑓𝑒𝑐𝑡𝑖𝑜𝑛 ℎ𝑎𝑠 𝑏𝑒𝑒𝑛 𝑐𝑙𝑒𝑎𝑟𝑒𝑑. #AntibioticsAugust #Infection #InfectionManagement #Orthopedics **𝑹𝒆𝒇𝒆𝒓𝒆𝒏𝒄𝒆𝒔 𝒄𝒂𝒏 𝒃𝒆 𝒇𝒐𝒖𝒏𝒅 𝒊𝒏 𝒕𝒉𝒆 𝒄𝒐𝒎𝒎𝒆𝒏𝒕𝒔.

🔍 Understanding Procalcitonin Interpretation in Clinical Practice 🔬 Procalcitonin (PCT) is a valuable biomarker that helps in diagnosing bacterial infections and guiding antimicrobial therapy decisions. Here’s a quick guide to interpreting PCT levels: 🧪 Normal PCT Levels (<0.1 ng/mL): Indicates a low likelihood of bacterial infection. Antibiotic therapy may not be necessary. 🧪 Low to Moderate Levels (0.1–0.5 ng/mL): Suggests a potential bacterial infection but might also be elevated due to other factors like trauma or surgery. Monitor closely and consider the clinical context. 🧪 High Levels (0.5–2.0 ng/mL): Indicates a probable bacterial infection. Antimicrobial therapy may be warranted based on clinical assessment. 🧪 Very High Levels (>2.0 ng/mL): Strongly suggests severe bacterial infection or sepsis. Immediate intervention and antimicrobial therapy are often necessary. 🔑 Key Points to Remember: Always interpret PCT levels alongside clinical signs, symptoms, and other laboratory findings. PCT can guide antibiotic stewardship by helping to avoid unnecessary antibiotic use and reducing antibiotic resistance. Effective PCT interpretation aids in timely and appropriate management, improving patient outcomes and promoting #AntimicrobialStewardship. 💡 #Procalcitonin #InfectionControl #ClinicalMicrobiology #QualityCare #Healthcare

🎥 We've got an exciting video featuring Dr. H. Erhan Güven! In this presentation, Dr. Güven takes us through 11 tough cases of diabetic foot attacks and necrotising fasciitis. He shows how DEBRICHEM® made a huge difference in these emergencies. From minor amputations to actually saving limbs, you’ll see impressive results. The patients, mostly around 58 years old and suffering from diabetes for about 15 years, faced serious infections. Thanks to DEBRICHEM®, we saw: ✅ No major amputations ✅ Successful angioplasty in 6 patients ✅ Fast granulation and healing ✅ Big drops in blood values indicating sepsis and infection Check out the video to see how DEBRICHEM® is changing the game in diabetic foot care. To further explore DEBRICHEM® and its applications, check out the following resources: 🚀 ✅ DEBRICHEM® Diabetic Foot: https://lnkd.in/dMq6F_SK ✅ Treating Wound Infections Without Antibiotics: https://lnkd.in/dE5rb9ph ✅ Developing a Clinical Pathway with DEBRICHEM®: https://lnkd.in/dgk697cP ✅ DEBRICHEM® in Home Care Setting: https://lnkd.in/dpuPqPrY ✅ Topical Use of DEBRICHEM® for the Treatment of Periungual Skin Lesions Post-Phenolization: A Case Series: https://lnkd.in/d58ruExm ✅ Pain Reception and Management During the Usage of DEBRICHEM®: https://lnkd.in/d5yzGmRe ✅ DEBRICHEM®: Biofilm Disruption Through Chemical Debridement: https://lnkd.in/dNXa_z2v ✅ DEBRICHEM® Wound Debridement: Integrating a Chemical Debridement Into a Clinical Pathway: https://lnkd.in/dedZqqNt ✅ A Parisian Case Series on DEBRICHEM® Use in the French Market: https://lnkd.in/djEQzUBD ✅ Using DEBRICHEM® for Specialized Wound Care Treatment in Primary Care: https://lnkd.in/dFjnByWV ✅ Efficacy of Chemical Debridement Agent on a Human Explant Model Infected by Biofilm: https://lnkd.in/d3xJexea Follow our LinkedIn page DEBx Medical to stay updated on our latest presentations and insights! #WoundCare #DiabeticFoot #DEBRICHEM #Healthcare #PatientCare

What we know: UTIs are a big issue for intermittent catheter users.¹ Antibiotic resistance from repeated use can be a health risk when treating recurrent urinary tract infections (UTIs)² and although intermittent catheters have improved, there can still be issues with UTIs.¹ Traditional hydrophilic catheters have coatings that make them slippery on the way in, but they can become sticky when removed.³ This can cause discomfort, bleeding, and damage to the urethra leading to a higher chance of getting UTIs.³,⁴ Without this coating, FeelClean Technology™ does not stick, so protects your delicate urethra,³,⁵ your body's first line of defense against UTIs.*,⁴ Independently tested against at Queen’s University Belfast. GentleCath™ with FeelClean Technology™ is designed to help improve outcomes and quality of life for intermittent catheter users.*,⁵ Watch this video to see how FeelClean Technology™ works. Learn more here: https://lnkd.in/eJMZMB3w #ForeverCaring #ForeverConvatec #ContinenceMatters 1. Engberg S, Clapper J, McNichol L, Thompson D, Welch VW, Gray M. Current Evidence Related to Intermittent Catheterization: A Scoping Review. J Wound Ostomy Continence Nurs. 2020;47(2):140-165. doi:10.1097/WON.0000000000000625 2. Rognoni C, Tarricone R. Intermittent catheterisation with hydrophilic and non-hydrophilic urinary catheters: systematic literature review and meta-analyses. BMC Urol. 2017;17(1):4. doi:10.1186/s12894-016-0191-1 3. Pollard D, Allen D, Irwin N J, Moore J V, McClelland N, McCoy C P. Evaluation of an Integrated Amphiphilic Surfactant as an Alternative to Traditional Polyvinylpyrrolidone Coatings for Hydrophilic Intermittent Urinary Catheters. Biotribology. 2022;32(Dec 2022):100223. 4. Dellimore KH, Helyer AR, Franklin SE. A scoping review of important urinary catheter induced complications. J Mater Sci Mater Med. 2013;24(8):1825-1835. doi:10.1007/s10856-013-4953-y 5. In vitro data on file. *Urethral trauma is a risk factor of UTIs

Infected F/BEVAR Explant Dear friends, Thank you again for the academic discussion about this case. Our decision to explant and stay out of the very purulent sac was based on the sac aspirant being frankly purulent and the microbiology consisting of gram positives, gram negatives and yeast (likely foregut source). Patient was treated with broad spectrum IV antibiotics and antifungals for a week prior to explant. Intraoperatively we noticed unexpected progression of infection transmurally into the supraceliac aorta. Our initial plan was to create a stump with the celiac beveled into it however the aorta, that looked ok on preop imaging, would not even hold a clamp and sutures kept tearing till I went about 6 centimeter above the celiac after temporary clamping above the branching allograft. There was pus within the wall of supraceliac aorta, something I have not seen before. Plan is to continue outpatient antibiotic and antifungal treatment for minimum of 6 months and continue interval imaging. This is our second instance of infection in a F/BEVAR in over 150 implants. Unfortunately graft infection, although rare, is something that we need to be prepared for. Strategies discussed on this thread are all appropriate options in different settings. I would love to hear more thoughts. #aortaed #unmvascularsurgery Gustavo Oderich MD Jesse Manunga Peter Gloviczki, MD, PhD Rafael Demarchi Malgor, MD, MBA FACS Faisal Aziz MD, MBA, FACS, Distinguished-FSVS Naveed Saqib Muhammad Aftab MD, FACS, FACC Ross Clark, MD, MBA, RPVI Firas Mussa

Mucormycosis is a rare and life-threatening infection caused by a group of fungi called mucormycetes. It can present in many forms, depending on which organs are affected. The first well-documented case was published in 1885 by German pathologist A. Paltauf in a paper called Mycosis mucorina. It described a case of a 52-year-old man with gastric and rhinocerebral involvement who ultimately died within the first 10 days of symptoms. We now present a terrible and yet fascinating case of a 61-year-old patient with bilateral rhino-orbital-cerebral mucormycosis who presented with extremely rare features, such as in vivo visualization of the fungus in the anterior chamber. As the infection was progressing from the paranasal sinus into the orbit and then to the cavernous sinus, the patient developed a striking sequence of clinical-anatomical findings:  - first, ipsilateral central retinal artery occlusion, then orbital apex syndrome, then cavernous sinus syndrome;  - after a few days, the infection invaded the contralateral cavernous sinus and progressed into the contralateral orbit, producing the same syndromes in a reverse sequence. Sadly, the patient has recently passed away, after more than a year fighting the infection. We would like to thank the patient and family for granting us permission to publish the case. He was always extremely brave, even in the face of such a dismal and relentless disease. Last but not least, a warm thank you to co-authors Margarida Dias and Guilherme Castela for their contributions to the case. https://lnkd.in/eNs53jmm

As Sepsis Awareness Month concludes, we share the story of Jeroen Bursens, who almost lost his life to this deadly disease, a condition that kills about one-third of the 49 million people it affects annually. Jeroen's hospital-acquired infection that triggered sepsis after a routine surgery highlights the critical need for early detection and treatment. Thermo Fisher's diagnostic tools play a vital role in this fight and help clinicians make informed decisions and improve patient outcomes. As we wrap up Sepsis Awareness Month, let's commit to spreading awareness and supporting advancements in sepsis detection and treatment for people like Jeroen and his family. #SepsisAwarenessMonth

As Sepsis Awareness Month concludes, we share the story of Jeroen Bursens, who almost lost his life to this deadly disease, a condition that kills about one-third of the 49 million people it affects annually. Jeroen's hospital-acquired infection that triggered sepsis after a routine surgery highlights the critical need for early detection and treatment. Thermo Fisher's diagnostic tools play a vital role in this fight and help clinicians make informed decisions and improve patient outcomes. As we wrap up Sepsis Awareness Month, let's commit to spreading awareness and supporting advancements in sepsis detection and treatment for people like Jeroen and his family. #SepsisAwarenessMonth

🦠 Infection Prevention: The last unmet need in orthopedic manufacturing Infection prevention is critical in any surgical procedure and continues to be one of the leading causes of revision surgeries. At Lincotek, with over 40 years of expertise in surface technology, we are at the forefront of addressing this important issue. Brandon Miller, our US Business Development Manager, shared his thoughts on this very topic at the latest #OMTEC conference and in our most recent blog! One of the most promising advancements in our approach is the use of nanostructured materials: Surfaces engineered at the microscopic level to have unique properties that resist bacterial colonization. Role of #NanostructuredMaterials in orthopedic implants: 📐 Increased Surface Area: #Nanostructures have a larger surface area, allowing them to overwhelm bacterial cells before they can proliferate. 😷 Antibacterial Agents: Some #Nanomaterials release antimicrobial ions or molecules that disrupt bacterial function, leading to cell death. 🔬 Tailored Coatings: Special #Coatings, such as those containing silver or zinc ions, enhance the antibacterial properties by creating an environment hostile to bacteria. Want to learn more about what surface technologies are worth the development expense? Read the full article: https://lnkd.in/dvyQkRJr Contact us to learn more about our solutions: https://lnkd.in/eCw4rPJP #Lincotek #ResearchandDevelopment #Innovation #SolutionProvider